Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Apr 30, 2024 12:55pm
144 Views
Post# 36015155

Take over negotiations

Take over negotiationsRepsaetng my previous comments.
First I have been part of 3 takeoversd that I can rememeber.
Most recent was in negotiations for 6 months. During that time the share price indiecate zero of such activity.
Once a deal was agreed to the floowing happened.
1. A N.R. came out discussing the "potential" deal.
2. A package was sent to shareholders giving complete timelines of the negotiations. All of which are logged druing meetings. Never disclosed publicly as that is first line of any negotiation. Called a non-disclosure agreement. The company cna do nothing to hint, or advance its image, beyond normal course updates. A.K.A required quarterly meetings etc.
ironically, the year end confernce call indiated all ahead with now changes. 
In the backgound they were into second round of back & forth price negotiations.
3. The shareholders the vote on the proposal, of the takeover.

Regretably at no time are any offers made pulic uuntil they get to the final stages.
As far as we know there could be mutiple offers or zero. Anyone clamiing they know are making things up.
The trading S.P. does not indicate any activity as, publicly there is none. That does not mean there is none.
Looking at the science there shulld be & verywell could be.
Managment has indicated " we continue dialog with our potential pharma colaboators"
Those hwo feel we sould be uodated on every offer? 
The shareholders regerttably do not have the busines or medical acumen to have that decsion.
Back to the one company I owned that was taken over.
Once they reached a reaonable agreement: An outsode agency was brought in, one for each company, to determine & give a legal opinon of fair value.
All fo that data was in my package explaing the negotiations and outside opinion of fair value.
For example: assuming Roshe makes an offer. nither Oncolytics want shareholder revolt for sellng too low, or Roche for paying to much.

Appying directly to ONC/ There are mnay who paid & have a $2/PS break even & would be  delighted to have $4ps. Others need $20Ps to break even.
That is why I keep saying the trading price is irreivant.

The outcome will be based on many factors of value.None of which which will inclsed the present day trading price.





<< Previous
Bullboard Posts
Next >>